174 related articles for article (PubMed ID: 3141516)
1. Effects of assay medium composition on macrophage-mediated tumor cell binding and lysis.
Hasday JD; Crawford EK
J Immunol Methods; 1988 Nov; 114(1-2):243-52. PubMed ID: 3141516
[TBL] [Abstract][Full Text] [Related]
2. The third component of complement (C3) bound to tumor target cells enhances their sensitivity to killing by activated macrophages.
Bara S; Lint TF
J Immunol; 1987 Feb; 138(4):1303-9. PubMed ID: 3100634
[TBL] [Abstract][Full Text] [Related]
3. High strength binding of P815 mastocytoma cells is not necessary for their lysis by macrophages which have been primed and triggered in vitro.
Lu CY; Lombardi MJ; Shea CM; Dustin LB
J Immunol; 1988 Aug; 141(4):1083-90. PubMed ID: 3135320
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of spontaneous macrophage-mediated cytolysis by eosinophil peroxidase.
Nathan CF; Klebanoff SJ
J Exp Med; 1982 May; 155(5):1291-308. PubMed ID: 6802924
[TBL] [Abstract][Full Text] [Related]
5. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
Leu RW; Leu NR; Shannon BJ; Fast DJ
J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
[TBL] [Abstract][Full Text] [Related]
6. Chronic exercise increases macrophage-mediated tumor cytolysis in young and old mice.
Lu Q; Ceddia MA; Price EA; Ye SM; Woods JA
Am J Physiol; 1999 Feb; 276(2):R482-9. PubMed ID: 9950928
[TBL] [Abstract][Full Text] [Related]
7. Culture medium induced morphological changes of melanoma cells associated with change in sensitivity to lysis by lymphokine-activated killer cells.
Perng YP; Lin CC; Perng IM; Shen YC; Chuang CK; Liao SK
Cancer Biother Radiopharm; 1997 Oct; 12(5):317-31. PubMed ID: 10851482
[TBL] [Abstract][Full Text] [Related]
8. Characterization of tumor binding by the IC-21 macrophage cell line.
Crawford EK; Latham PS; Shah EM; Hasday JD
Cancer Res; 1990 Aug; 50(15):4578-83. PubMed ID: 2164442
[TBL] [Abstract][Full Text] [Related]
9. Differential sensitivity of tumor targets to liver macrophage-mediated cytotoxicity.
Gardner CR; Wasserman AJ; Laskin DL
Cancer Res; 1987 Dec; 47(24 Pt 1):6686-91. PubMed ID: 3119198
[TBL] [Abstract][Full Text] [Related]
10. Use of serum-free, compositionally defined medium for analysis of macrophage differentiation in vitro.
Vogel SN; Perera PY; Hogan MM; Majde JA
J Leukoc Biol; 1988 Aug; 44(2):136-42. PubMed ID: 2457063
[TBL] [Abstract][Full Text] [Related]
11. Induction of macrophage-mediated cytolysis of neoplastic cells by mycoplasmas.
Loewenstein J; Rottem S; Gallily R
Cell Immunol; 1983 Apr; 77(2):290-7. PubMed ID: 6850843
[TBL] [Abstract][Full Text] [Related]
12. Direct activation of murine peritoneal macrophages for nitric oxide production and tumor cell killing by interferon-gamma.
Dileepan KN; Page JC; Li Y; Stechschulte DJ
J Interferon Cytokine Res; 1995 May; 15(5):387-94. PubMed ID: 7648440
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of murine macrophage-mediated tumor cytotoxicity induced by interferons.
Koestler TP; Johnson WJ; Rieman D; Dalton BJ; Greig RG; Poste G
Cancer Res; 1987 Jun; 47(11):2804-8. PubMed ID: 2436758
[TBL] [Abstract][Full Text] [Related]
14. Antibody-dependent cytolysis (ADCC) of tumor cells by activated murine macrophages is a two-step process: quantification of target binding and subsequent target lysis.
Johnson WJ; Bolognesi DP; Adams DO
Cell Immunol; 1984 Jan; 83(1):170-80. PubMed ID: 6420078
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of target recognition and destruction in macrophage-mediated tumor cytotoxicity.
Adams DO; Johnson WJ; Marino PA
Fed Proc; 1982 Apr; 41(6):2212-21. PubMed ID: 6804274
[TBL] [Abstract][Full Text] [Related]
16. The capacity of activated murine macrophages for augmented binding of neoplastic cells: analysis of induction by lymphokine containing MAF and kinetics of the reaction.
Marino PA; Adams DO
J Immunol; 1982 Jun; 128(6):2816-23. PubMed ID: 6804569
[TBL] [Abstract][Full Text] [Related]
17. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
Hogan MM; Vogel SN
J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
[TBL] [Abstract][Full Text] [Related]
18. Correlation of macrophage-mediated tumor-cell lysis with the production of macrophage cytolytic factor (CF). Preliminary characterization of a factor inhibiting CF production.
Gifford GE; Loewenstein J; Yamin A; Gallily R
Int J Cancer; 1986 Jan; 37(1):73-9. PubMed ID: 3753597
[TBL] [Abstract][Full Text] [Related]
19. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
20. Variation in selectivity of tumor cell cytolysis by murine macrophages, macrophage-like cell lines and NK cells.
Wiltrout RH; Brunda MJ; Holden HT
Int J Cancer; 1982 Sep; 30(3):335-42. PubMed ID: 6813271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
